[IMRX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[IMRX] Immuneering Corporation
Announcement Date
01-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -8.50%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 0 317 2,080 2,312 1,920 -
PBT -53,472 -50,514 -33,843 -17,040 -7,709 62.23%
Tax 0 -1,232 -307 -84 351 -
NP -53,472 -49,282 -33,536 -17,040 -8,061 60.43%
Tax Rate - - - - - -
Total Cost 53,472 49,599 35,616 19,351 9,980 52.09%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 0.00 -15,548.66 -1,612.33 -737.17 -419.89 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.88 -1.87 -1.27 -0.67 -0.32 55.63%
EPS Diluted -1.88 -1.87 -1.27 -0.67 -0.32 55.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.